0001104659-26-024676
SEC filingTvardi Therapeutics, Inc. has set June 9, 2026 as the date for its 2026 Annual Meeting of Stockholders. The filing specifies deadlines for stockholder proposals under Rule 14a-8 (March 16, 2026), advance notice bylaws (March 16, 2026), and Rule 14a-19 universal proxy notices (April 10, 2026).